Back to 
UBS Group AG
UBS Group AG
LIMN5 quarters
Position history for UBS Group AG's holdings in LIMINATUS PHARMA INC.
UBS Group AG holds 16,730 shares of LIMN (LIMINATUS PHARMA INC.), worth $1,840 as of 2026-Q2. The position was decreased (-69.3% shares).
Current Value
$1,840
Current Shares
16,730
Total Value Change
-$349,229
Total Shares Change
-14,756
Quarter-by-Quarter History
Other major holders of LIMN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BlackRock, Inc.